Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure

Archives of Gynecology and Obstetrics
Recep YildizhanNecdet Suer

Abstract

The aim of this study is to compare the effect of ethinyl estradiol 0.03 mg/gestodene 0.075 mg (EE/GSD) with ethinylestradiol 0.03 mg/drospirenone 3 mg (EE/DRSP) administered according to conventional 21/7 regimen on body mass index (BMI), blood pressure (BP), lipid metabolism and hemostatic parameters. In this study, 160 healthy women were randomized to EE/GSD mg or EE/DRSP for 12 months. Mean differences in BMI, high density lipoprotein-cholesterol (HDL-C) and low density lipoprotein-cholesterol (LDL-C), total cholesterol (TC) levels and BP compared to baseline were assessed. One hundred and forty-five (89%) of the women completed all 12 treatment cycles. The subjects randomly assigned into two treatment groups. Group EE/GSD (n = 71) and group EE/DRSP (n = 72). In group B, BMI values were significantly lower than baseline at the sixth cycle. DRSP/EE had more favorable effects on BP than GSD/EE with the mean systolic and diastolic BPs remaining lower in the DRSP/EE group. The difference between the two preparations was not statistically significant at the end of the study. TC levels remained similar in both groups throughout the study period. In both groups LDL-C levels decreased, triglyceride and HDL-C levels significantly in...Continue Reading

References

Nov 1, 1976·The Journal of Clinical Endocrinology and Metabolism·W OelkersJ Hammerstein
Oct 1, 1992·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·M J Rosenberg, S C Long
Nov 15, 1990·The New England Journal of Medicine·I F GodslandV Wynn
Mar 1, 1990·European Journal of Obstetrics, Gynecology, and Reproductive Biology·N B LoudonJ A Dewsbury
Jan 5, 1985·British Medical Journal·P B RylanceJ W Studd
Oct 1, 1969·Steroids·S L SteelmanD J Patanelli
Jun 12, 1995·Annals of the New York Academy of Sciences·P MuhnE Schillinger
Mar 1, 1993·American Journal of Obstetrics and Gynecology·R T Burkman
Aug 3, 2000·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·W OelkersR Heithecker
Dec 22, 2000·Contraception·D PaulusM Jeanjean
Jul 21, 2001·BMJ : British Medical Journal·J M KemmerenD E Grobbee
Jan 10, 2002·Fertility and Sterility·Marcelle I Cedars
Mar 15, 2006·Contraception·Rogério Bonassi MachadoEdna Maia
Jul 10, 2007·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Surasak Taneepanichskul, Vorapong Phupong

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.